Institut Químic de Sarrià, Universitat Ramon Llull, Barcelona 08017, Spain.
J Med Chem. 2010 Nov 11;53(21):7796-803. doi: 10.1021/jm1009555.
Structures of typical photosensitizers used in antimicrobial photodynamic therapy are based on porphyrins, phthalocyanines, and phenothiazinium salts, with cationic charges at physiological pH values. However, derivatives of the porphycene macrocycle (a structural isomer of porphyrin) have barely been investigated as antimicrobial agents. Therefore, we report the synthesis of the first tricationic water-soluble porphycene and its basic photochemical properties. We successfully tested it for in vitro photoinactivation of different Gram-positive and Gram-negative bacteria, as well as a fungal species (Candida) in a drug-dose and light-dose dependent manner. We also used the cationic porphycene in vivo to treat an infection model comprising mouse third degree burns infected with a bioluminescent methicillin-resistant Staphylococcus aureus strain. There was a 2.6-log(10) reduction (p < 0.001) of the bacterial bioluminescence for the PDT-treated group after irradiation with 180 J·cm(-2) of red light.
典型的用于抗菌光动力疗法的光敏剂结构基于卟啉、酞菁和吩噻嗪盐,在生理 pH 值下带有正电荷。然而,卟吩嗪大环(卟啉的结构异构体)的衍生物几乎没有被研究作为抗菌剂。因此,我们报告了首例三阳离子水溶性卟吩嗪的合成及其基本光化学性质。我们成功地测试了它对不同革兰氏阳性和革兰氏阴性细菌以及一种真菌(念珠菌)的体外光灭活作用,具有药物剂量和光照剂量依赖性。我们还在体内使用阳离子卟吩嗪治疗包含感染生物发光性耐甲氧西林金黄色葡萄球菌的三度烧伤小鼠的感染模型。在 180 J·cm(-2) 的红光照射下,光动力治疗组的细菌生物发光减少了 2.6 个对数(p < 0.001)。